US pharmaceutical corporation Pfizer and Germany‘s BioNTech a collaboration with Biovac in South Africa, the only Southern African human vaccines manufacturer, to fill and distribute mRNA vaccine doses across the African Union. While this deal is a step in the right direction, much more is needed to support vaccine independence in Africa—a continent where people remain in desperate need of vaccines as they face new waves of infection, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF).        
